Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bricanyl Turbuhaler M3 vs M2 methacholine challenge equivalence study in mild to moderate asthma
2014-001457-16Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of terbutaline in asthma (2 arms), sponsored by AstraZeneca. Primary endpoint: Therapeutic equivalence in bronchoprotective effect. Started Dec 2014; status: completed.
02
Drugs
terbutaline
03
Conditions
asthma
Beyond the preview
Go deeper on 2014-001457-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-001457-16.